BusinessHistogenics Announces Publication of Additional Biomechanical Data From Human Engineered Cartilage TestingBy Nasdaq OMXOct 2, 2017, 8:15 PM UTC
BusinessHistogenics Corporation to Present at the 2017 Cell & Gene Meeting on the MesaBy Nasdaq OMXSep 26, 2017, 12:30 PM UTC
BusinessHistogenics Corporation to Present at Upcoming Investor ConferencesBy Nasdaq OMXAug 24, 2017, 12:30 PM UTC
BusinessHistogenics Corporation Announces Second Quarter 2017 Financial and Operating ResultsBy Nasdaq OMXAug 10, 2017, 10:30 AM UTC
BusinessHistogenics Announces Publication of Data From Collagen and Chondrocyte 3-D Bioprinting StudyBy Nasdaq OMXJul 11, 2017, 12:30 PM UTC
BusinessHistogenics Completes Enrollment for Phase 3 Clinical Trial of Neocart® to Treat Knee Cartilage DamageBy Nasdaq OMXJun 27, 2017, 8:01 PM UTC
